Pfizer, GSK & Sanofi take issue with FDA’s CMO Guidance

http://genericpharmalitigator.com/wp-content/uploads/2013/09/wpid-curata__00422579b906e485d85aeb3fae05661f2.gif

Pfizer, GSK, Sanofi, Others Take Issue with FDA’s CMO Draft Guidance

http://t.co/78oX773rRw #pharma

Read the source article at Pharmaceutical Industry – News from In